Headline News about Apellis Pharmaceuticals, Inc. - Common Stock

Analyst Expectations For Apellis Pharmaceuticals's Future
January 21, 2025
Via Benzinga


This Match Group Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
December 17, 2024
Via Benzinga

Via Benzinga

Via Benzinga

Energizer, C3.ai, Insmed And Other Big Stocks Moving Higher On Tuesday
November 19, 2024
Via Benzinga

A Glimpse of Apellis Pharmaceuticals's Earnings Potential
November 04, 2024
Via Benzinga

The Latest Analyst Ratings For Apellis Pharmaceuticals
November 04, 2024
Via Benzinga

Via Benzinga




12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 05, 2024
Via Benzinga

Navigating 18 Analyst Ratings For Apellis Pharmaceuticals
October 16, 2024
Via Benzinga

Analyst Scoreboard: 15 Ratings For Apellis Pharmaceuticals
September 13, 2024
Via Benzinga




CrowdStrike To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Monday
September 23, 2024
Via Benzinga




Via Benzinga






Expert Ratings For Apellis Pharmaceuticals
April 15, 2024
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.